Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 14.53 USD 0.28% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Progyny Inc?
Write Note

Progyny Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Progyny Inc
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Progyny Inc
NASDAQ:PGNY
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
UnitedHealth Group Inc
NYSE:UNH
Current Portion of Long-Term Debt
$3.9B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
3%
Centene Corp
NYSE:CNC
Current Portion of Long-Term Debt
$111m
CAGR 3-Years
-23%
CAGR 5-Years
11%
CAGR 10-Years
36%
Molina Healthcare Inc
NYSE:MOH
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Humana Inc
NYSE:HUM
Current Portion of Long-Term Debt
$1.1B
CAGR 3-Years
13%
CAGR 5-Years
23%
CAGR 10-Years
8%
Elevance Health Inc
NYSE:ELV
Current Portion of Long-Term Debt
$2.1B
CAGR 3-Years
35%
CAGR 5-Years
25%
CAGR 10-Years
13%
No Stocks Found

Progyny Inc
Glance View

Market Cap
1.3B USD
Industry
Health Care

In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.

PGNY Intrinsic Value
38.85 USD
Undervaluation 63%
Intrinsic Value
Price

See Also

Back to Top